CD16A levels on the surface of NK cells are downregulated in the tumor microenvironment of colorectal carcinoma (80), ovarian carcinoma (81), head and neck cancers (82), breast cancer (122) and melanoma (79), contributing to NK cell dysfunction. The gene discussed is FCGR3A; the disease is colorectal carcinoma.